2-Aryl-Benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium tuberculosis .

MLA

Saha, Pallavi, et al. “2-Aryl-Benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium Tuberculosis .” ACS Infectious Diseases, vol. 10, no. 10, Oct. 2024, pp. 3699–711. EBSCOhost, https://doi.org/10.1021/acsinfecdis.4c00710.

APA

Saha, P., Sau, S., Kalia, N. P., & Sharma, D. K. (2024). 2-Aryl-Benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium tuberculosis . ACS Infectious Diseases, 10(10), 3699–3711. https://doi.org/10.1021/acsinfecdis.4c00710

Chicago

Saha, Pallavi, Shashikanta Sau, Nitin Pal Kalia, and Deepak K Sharma. 2024. “2-Aryl-Benzoimidazoles as Type II NADH Dehydrogenase Inhibitors of Mycobacterium Tuberculosis .” ACS Infectious Diseases 10 (10): 3699–3711. doi:10.1021/acsinfecdis.4c00710.